Responsiveness of the 36-item short form health survey and the lupus quality of life questionnaire in SLE

Rheumatology (United Kingdom)

Volumn 54, Issue 5, 2014, Pages 940-949

  Devilliers, Hervé ^a   Amoura, Zahir ^b   Besancenot, Jean François ^a   Bonnotte, Bernard ^a   Pasquali, Jean Louis ^c   Wahl, Denis ^d   Maurier, Francois ^e   Kaminsky, Pierre ^d   Pennaforte, Jean Loup ^f   Magy Bertrand, Nadine ^g   Arnaud, Laurent ^b   Binquet, Christine ^a   Guillemin, Francis ^d   Bonithon Kopp, Claire ^a  

^a DIJON UNIVERSITY HOSPITAL   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^d UNIVERSITY HOSPITAL OF NANCY   (France)

^e Department of Internal Medicine   (France)

^f SERVICE DE DERMATOLOGIE   (France)

^g UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

Author keywords

Outcome assessment; Psychometrics; Quality of life; SLE

Indexed keywords

ADULT; AGED; ARTICLE; BODY IMAGE; CLINICAL ASSESSMENT; COHORT ANALYSIS; FATIGUE; FEMALE; HEALTH STATUS; HUMAN; LIKERT SCALE; LUPUS QUALITY OF LIFE QUESTIONNAIRE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; SCORING SYSTEM; SHORT FORM 36; SLEDAI; SYSTEMIC LUPUS ERYTHEMATOSUS; VISUAL ANALOG SCALE;

EID: 84929663819     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keu410     Document Type: Article

References (28)

1. Arnaud L, Devilliers H, Mathian A, Amoura Z. Le lupus systé mique est une maladie rare: é tude de pré valence en population gé né rale sur l'ensemble du territoire Français. Rev Med Interne 2012;33:A80.
2. Dubois EL. Dubois' Lupus Erythematosus. 7th rev. edn. Philadelphia, PA, USA: Lippincott Williams and Wilkins, 2006:1440.
3. Strand V, Gladman D, Isenberg D et al. Endpoints: consensus recommendations from OMERACT IV. Outcome measures in rheumatology. Lupus 2000;9:322-7.
4. McElhone K, Abbott J, Teh L-S. A review of health related quality of life in systemic lupus erythematosus. Lupus 2006;15:633-43.
5. McElhone K, Abbott J, Shelmerdine J et al. Development and validation of a disease-specific health-related quality of life measure, the LupusQoL, for adults with systemic lupus erythematosus. Arthritis Rheum 2007;57:972-9.
6. Leong KP, Kong KO, Thong BYH et al. Development and preliminary validation of a systemic lupus erythematosusspecific quality-of-life instrument (SLEQOL). Rheumatology 2005;44:1267-76.
7. Jolly M, Pickard AS, Block JA et al. Disease-specific patient reported outcome tools for systemic lupus erythematosus. Semin Arthritis Rheum 2012;42:56-65.
8. Doward LC, McKenna SP, Whalley D et al. The development of the L-QoL: a quality-of-life instrument specific to systemic lupus erythematosus. Ann Rheum Dis 2009;68:196-200.
9. Grootscholten C, Ligtenberg G, Derksen RHWM et al. Health-related quality of life in patients with systemic lupus erythematosus: development and validation of a lupus specific symptom checklist. Qual Life Res 2003;12:635-44.
10. Yee C-S, McElhone K, Teh L-S, Gordon C. Assessment of disease activity and quality of life in systemic lupus erythematosus:new aspects. Best Pract Res Clin Rheumatol 2009;23:457-67.
11. Castelino M, Abbott J, McElhone K, Teh L-S. Comparison of the psychometric properties of health-related quality of life measures used in adults with systemic lupus erythematosus:a review of the literature. Rheumatology 2013; 52:684-96.
12. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
13. Devilliers H, Amoura Z, Besancenot J-F et al. LupusQoLFR is valid to assess quality of life in patients with systemic lupus erythematosus. Rheumatology 2012;51:1906-15.
14. Devilliers H, Guillemin F, Besancenot J-F et al. Validation transculturelle en langue française du systemic lupus activity questionnaire. Rev Med Interne 2009;30:S376.
15. Karlson EW, Daltroy LH, Rivest C et al. Validation of a Systemic Lupus Activity Questionnaire (SLAQ) for population studies. Lupus 2003;12:280-6.
16. Leplège A, Ecosse E, Verdier A, Perneger TV. The French SF-36 Health Survey: translation, cultural adaptation and preliminary psychometric evaluation. J Clin Epidemiol 1998;51:1013-23.
17. Petri M, Kim MY, Kalunian KC et al. Combined oral contraceptives in women with systemic lupus erythematosus. N Engl J Med 2005;353:2550-8.
18. Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care 2003; 41:582-92.
19. Crosby RD, Kolotkin RL, Williams GR. Defining clinically meaningful change in health-related quality of life. J Clin Epidemiol 2003;56:395-407.
20. Copay AG, Subach BR, Glassman SD, Polly DW Jr, Schuler TC. Understanding the minimum clinically important difference: a review of concepts and methods. Spine J 2007;7:541-6.
21. Kosinski M, Zhao SZ, Dedhiya S, Osterhaus JT, Ware JE Jr. Determining minimally important changes in generic and disease-specific health-related quality of life questionnaires in clinical trials of rheumatoid arthritis. Arthritis Rheum 2000;43:1478-87.
22. Colangelo KJ, Pope JE, Peschken C. The minimally important difference for patient reported outcomes in systemic lupus erythematosus including the HAQ-DI, pain, fatigue, and SF-36. J Rheumatol 2009;36:2231-7.
23. Touma Z, Gladman DD, Ibañez D, Urowitz MB. Is there an advantage over SF-36 with a quality of life measure that is specific to systemic lupus erythematosus? J Rheumatol 2011;38:1898-905.
24. Conti F, Perricone C, Reboldi G et al. Validation of a disease- specific health-related quality of life measure in adult Italian patients with systemic lupus erythematosus:LupusQoL-IT. Lupus 2014;23:743-51.
25. Wang S, Wu B, Leng L, Bucala R, Lu L. Validity of LupusQoL-China for the assessment of health related quality of life in Chinese patients with systemic lupus erythematosus. PLoS One 2013;8:e63795.
26. González-Rodri{dotless}guez V, Peralta-Rami{dotless}rez MI, Navarrete-Navarrete N et al. [Adaptation and validation of the Spanish version of a disease-specific quality of life measure in patients with systemic lupus erythematosus:the lupus quality of life]. Med Clin 2010;134:13-6.
27. Garci{dotless}a-Carrasco M, Mendoza-Pinto C, Cardiel MH et al. Health related quality of life in Mexican women with systemic lupus erythematosus: a descriptive study using SF-36 and LupusQoL(C). Lupus 2012;21:1219-24.
28. Patrick DL, Deyo RA. Generic and disease-specific measures in assessing health status and quality of life. Med Care 1989;27(Suppl):S217-32.